Among this family of Receptor Tyrosine Kinases (RTKs), HER2 has a central role in the sustained activity of the transcription factor NF-κB in cancer cells (99), promoting the phosphorylation and activation of IKK by AKT, one of its downstream effectors (Figure 3A). The gene discussed is AKT1; the disease is cancer.